UNSPSC 85814901: Introduction of destructive agent into male reproductive, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of destructive agent into male reproductive, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0N3TZ

UNSPSC 85814901, Introduction of destructive agent into male reproductive, percutaneous approach, is a Commodity code that shows minimal recent alignment with state and local procurement activity. The code's clinical scope—a medical procedure involving reproductive intervention—does not match the recent solicitations tagged under it, which instead address telehealth urgent care, occupational health services, cancer screening, nursing home operations, opioid use disorder treatment, mental health programs, and various other behavioral and clinical health services. State and local governments are not actively procuring this specific procedure; the code appears to be a taxonomy classification error in the available opportunities.

The mismatch is fundamental. Recent opportunities under this code identifier include Inland Empire Health Plan's request for 24/7 virtual urgent care services in California (due October 31, 2026); the Nevada Health Authority's PACE program for elderly adults across multiple counties (due December 10, 2026); and multiple behavioral health, occupational health, substance use disorder treatment, and medical staffing solicitations from counties and state health agencies nationwide. None of these opportunities involve the procedure named in the code. The opportunities span issuing bodies across California, Nevada, Georgia, Florida, Colorado, Texas, Kansas, Arizona, Missouri, and other states, but they reflect a fragmented procurement landscape organized around general health services delivery rather than the specific clinical procedure the code nominally describes. Without recent, verified opportunities actually soliciting under this code's intended scope, this category warrants monitoring rather than active pursuit unless your firm operates within the clinical procedure domain and expects taxonomy corrections to emerge in future RFPs.